Goldman Sachs’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-321,553
| Closed | -$6.42M | – | 5690 |
|
2022
Q3 | $6.42M | Buy |
321,553
+135,211
| +73% | +$2.7M | ﹤0.01% | 2463 |
|
2022
Q2 | $1.28M | Sell |
186,342
-72,394
| -28% | -$498K | ﹤0.01% | 3775 |
|
2022
Q1 | $2.41M | Sell |
258,736
-14,117
| -5% | -$131K | ﹤0.01% | 3441 |
|
2021
Q4 | $3.88M | Buy |
272,853
+78,308
| +40% | +$1.11M | ﹤0.01% | 3009 |
|
2021
Q3 | $4.51M | Buy |
194,545
+30,810
| +19% | +$714K | ﹤0.01% | 2862 |
|
2021
Q2 | $4.08M | Sell |
163,735
-17,151
| -9% | -$427K | ﹤0.01% | 2939 |
|
2021
Q1 | $5.07M | Buy |
180,886
+60,188
| +50% | +$1.69M | ﹤0.01% | 2656 |
|
2020
Q4 | $4.21M | Buy |
+120,698
| New | +$4.21M | ﹤0.01% | 2565 |
|
2020
Q3 | – | Sell |
-96,597
| Closed | -$4.49M | – | 4619 |
|
2020
Q2 | $4.49M | Buy |
+96,597
| New | +$4.49M | ﹤0.01% | 2390 |
|